002932 明德生物
2025/09 - 九个月
人民币(K¥)
2024/12
人民币(K¥)
2023/12
人民币(K¥)
2022/12
人民币(K¥)
2021/12
人民币(K¥)
经营活动产生之现金流量净额(88,402)(85,046)392,4984,012,8481,127,006
投资活动产生之现金流量净额174,181(138,125)(1,365,066)(2,234,199)(685,118)
筹资活动产生之现金流量净额(279,481)(313,168)(670,060)(432,790)82,272
汇率变动对现金及现金等价物的影响(640)5061,26219,471(3,196)
现金及现金等价物净增加/(减少)(194,342)(535,833)(1,641,365)1,365,330520,964
期初现金及现金等价物余额378,207914,0402,555,4051,190,075669,111
期末现金及现金等价物余额183,864378,207914,0402,555,4051,190,075